Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that proper diagnosis and long-term treatment, including medication, hair removal, and lifestyle changes, are important for improving hirsutism, especially in PCOS patients.

Adult female acne is complex and requires a combination of treatments for effective management.

Acne is a common skin condition linked to diet, hormones, and genetics, and early treatment can prevent scarring.

The conclusion is that obesity should be managed with a slow, balanced approach to diet and exercise, with medication and surgery as additional options, and education and access to care are important.

The study found that PCOS affects about 6.5-6.8% of women in both urban and rural areas of Telangana, India, and highlighted the importance of lifestyle changes for management.

PCOS is a common and costly condition in North American women, causing various health issues like obesity, diabetes, and fertility problems.

Some lesser-known causes of PCOS include autoimmune issues, genetic mutations, and changes in the body's microbiome.

Flutamide combined with a low-dose birth control pill effectively reduces excessive hair growth in women with polycystic ovarian disease.

The document says that hirsutism in women usually needs hair removal and hormone treatment to manage symptoms and improve well-being.

The document concludes that more multidisciplinary research is needed to understand and treat PCOS, a condition that significantly affects women's health and quality of life.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

The document concluded that more research is needed to understand how estrogen affects the enzyme involved in hirsutism development.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

The oral contraceptive with ethinyl estradiol and chlormadinone acetate is effective in treating moderate acne.

Cyproterone acetate with ethinyl estradiol is effective for treating skin symptoms related to high androgen levels, like in PCOS.

The paper suggests that France's suspension of Diane-35 was hasty and could cause treatment issues and unintended pregnancies, recommending a re-evaluation and better patient information.

Birth control pills with low-dose estrogen and antiandrogenic progestins can effectively treat acne.

People with PCOS have higher levels of PAI-1, which may increase their risk of heart disease and fertility issues.

Combining letrozole with metformin is the most effective treatment for inducing pregnancy in women with PCOS.

A certain genetic variation is linked to a higher risk of polycystic ovarian syndrome.

Myoinositol helps improve menstrual cycles and some skin issues in women with PCOS.

N-acetylcysteine was more effective and had fewer side effects than metformin for improving insulin resistance in women with PCOS.

A 17-year-old girl was diagnosed with a rare ovarian tumor, emphasizing the need for fertility preservation and psychosocial care.

PCOS is common in young women, especially those aged 21-30, and often involves symptoms like irregular periods, weight gain, and acne.

Higher testosterone levels in Nigerian women with PCOS are linked to glucose disorders like diabetes.

Non-daily contraceptives cause fewer side effects and are more satisfying to women, and certain oral contraceptives can treat acne and seborrhoea, with a combination of chlormadinone acetate and ethinyl estradiol being highly effective and safe.

Polycystic Ovary Syndrome (PCOS) is common in infertile women and obese women with PCOS have more severe ovulatory problems, needing more care.

Women with newly diagnosed PCOS may have worse gum health than those treated for PCOS.

Cyproterone acetate is effective for acne but less so for hirsutism and alopecia, with some side effects and quick menstrual cycle recovery after treatment.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.